Dogwood Therapeutics DWTX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's operating income?
- Dogwood Therapeutics (DWTX) reported operating income of -$5.08M in Q1 2026.
- How has Dogwood Therapeutics's operating income changed year-over-year?
- Dogwood Therapeutics's operating income decreased by 14.6% year-over-year, from -$4.43M to -$5.08M.
- What is the long-term trend for Dogwood Therapeutics's operating income?
- Over 4 years (2021 to 2025), Dogwood Therapeutics's operating income has grown at a 15.6% compound annual growth rate (CAGR), from -$15.64M to -$27.97M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.